IDEXX Laboratories Inc (IDXX) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally.
Total Cash From Operating Activities Chart for IDEXX Laboratories Inc
IDEXX Laboratories Inc (IDXX) operating cash flow for FY2025 was USD 1.2B, a 26.8% change from FY2024. IDEXX Laboratories Inc's operating cash flow grew from USD 3.8M in 1991 to USD 1.2B in 2025 (30901.8% over 34 years). Operating cash flow compound annual growth rate: 5-year CAGR of 12.7%, 10-year CAGR of 18.5%, 20-year CAGR of 12.3%.
Total Cash From Operating Activities (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $46.54B
- Implied Share Price
- $590.00
- Enterprise Value
- $47.30B
- Revenue (TTM)
- $4.55B
- EBITDA
- $1.62B
- Profit Margin
- 25.03%
- Trailing P/E
- 41.14
- Forward P/E
- 39.84
- Price/Book (MRQ)
- 29.81
- Price/Sales (TTM)
- 10.21
- EV/EBITDA
- 30.37
- EV/Revenue
- 10.64
- Dividend Yield
- —
- Book Value
- $19.64
- Free Cash Flow (FY2025)
- $1.05B
- Free Cash Flow Yield
- 2.26%
Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.